Microbot Medical MBOT Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's additional paid-in capital?
- Microbot Medical (MBOT) reported additional paid-in capital of $181.19M in Q1 2026.
- How has Microbot Medical's additional paid-in capital changed year-over-year?
- Microbot Medical's additional paid-in capital increased by 48.3% year-over-year, from $122.15M to $181.19M.
- What is the long-term trend for Microbot Medical's additional paid-in capital?
- Over 5 years (2020 to 2025), Microbot Medical's additional paid-in capital has grown at a 21.4% compound annual growth rate (CAGR), from $68.52M to $180.97M.
- What does additional paid-in capital mean?
- This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.